246 related articles for article (PubMed ID: 23322214)
1. Mucosal Lactobacillus vectored vaccines.
Yu Q; Zhu L; Kang H; Yang Q
Hum Vaccin Immunother; 2013 Apr; 9(4):805-7. PubMed ID: 23322214
[TBL] [Abstract][Full Text] [Related]
2.
LeCureux JS; Dean GA
mSphere; 2018; 3(3):. PubMed ID: 29769376
[TBL] [Abstract][Full Text] [Related]
3. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.
Noh YW; Hong JH; Shim SM; Park HS; Bae HH; Ryu EK; Hwang JH; Lee CH; Cho SH; Sung MH; Poo H; Lim YT
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7684-9. PubMed ID: 23765547
[TBL] [Abstract][Full Text] [Related]
4. Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.
Poles J; Alvarez Y; Hioe CE
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1027-40. PubMed ID: 25354023
[TBL] [Abstract][Full Text] [Related]
5. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
Nakahashi-Ouchida R; Yuki Y; Kiyono H
Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
[TBL] [Abstract][Full Text] [Related]
6. Comparison of eight Lactobacillus species for delivery of surface-displayed mycobacterial antigen.
Kuczkowska K; Øverland L; Rocha SDC; Eijsink VGH; Mathiesen G
Vaccine; 2019 Oct; 37(43):6371-6379. PubMed ID: 31526620
[TBL] [Abstract][Full Text] [Related]
7. Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.
Amuguni H; Tzipori S
Hum Vaccin Immunother; 2012 Jul; 8(7):979-86. PubMed ID: 22699442
[TBL] [Abstract][Full Text] [Related]
8. Mucosal vaccine delivery: Current state and a pediatric perspective.
Shakya AK; Chowdhury MYE; Tao W; Gill HS
J Control Release; 2016 Oct; 240():394-413. PubMed ID: 26860287
[TBL] [Abstract][Full Text] [Related]
9. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.
Czerkinsky C; Svennerholm AM; Holmgren J
Clin Infect Dis; 1993 Mar; 16 Suppl 2():S106-16. PubMed ID: 8452962
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization.
Stano A; Nembrini C; Swartz MA; Hubbell JA; Simeoni E
Vaccine; 2012 Dec; 30(52):7541-6. PubMed ID: 23103199
[TBL] [Abstract][Full Text] [Related]
11. New generation of oral mucosal vaccines targeting dendritic cells.
Owen JL; Sahay B; Mohamadzadeh M
Curr Opin Chem Biol; 2013 Dec; 17(6):918-24. PubMed ID: 23835515
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization: a review of strategies and challenges.
Patel H; Yewale C; Rathi MN; Misra A
Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
[TBL] [Abstract][Full Text] [Related]
13. Intranasal formulations: promising strategy to deliver vaccines.
Riese P; Sakthivel P; Trittel S; Guzmán CA
Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
[TBL] [Abstract][Full Text] [Related]
14. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
Mishra N; Singh D; Sharma S; Baldi A
Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.
Henderson A; Propst K; Kedl R; Dow S
Vaccine; 2011 Jul; 29(32):5304-12. PubMed ID: 21600950
[TBL] [Abstract][Full Text] [Related]
16. Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
Bumgardner SA; Zhang L; LaVoy AS; Andre B; Frank CB; Kajikawa A; Klaenhammer TR; Dean GA
PLoS One; 2018; 13(5):e0196950. PubMed ID: 29734365
[TBL] [Abstract][Full Text] [Related]
17. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
18. Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.
Bolton DL; Song K; Tomaras GD; Rao S; Roederer M
Vaccine; 2017 Jan; 35(4):639-646. PubMed ID: 28041780
[TBL] [Abstract][Full Text] [Related]
19. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.
Nizard M; Diniz MO; Roussel H; Tran T; Ferreira LC; Badoual C; Tartour E
Hum Vaccin Immunother; 2014; 10(8):2175-87. PubMed ID: 25424921
[TBL] [Abstract][Full Text] [Related]
20. Lectins and microparticles for enhanced oral vaccination.
Lavelle EC
Methods; 2006 Feb; 38(2):84-9. PubMed ID: 16406570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
